HIV and human complement: inefficient virolysis and effective adherence

Immunol Lett. 2005 Mar 15;97(2):209-14. doi: 10.1016/j.imlet.2004.11.007. Epub 2004 Nov 28.

Abstract

Both, HIV envelope proteins gp120 and gp41 can directly activate complement system, even in the absence of HIV-specific antibodies. During the budding process HIV acquires host membrane-associated molecules among these complement regulatory proteins (CRPs). The presence of CRPs on the viral surface rescues HIV from complement-mediated virolysis. The inefficient virolysis results in the deposition of complement-fragments on the viral surface allowing interactions of HIV with complement receptor expressing cells. In this review, the interaction of HIV with the complement system and the consequences of complement opsonisation on virus infection will be discussed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acquired Immunodeficiency Syndrome / immunology*
  • Acquired Immunodeficiency Syndrome / pathology
  • Acquired Immunodeficiency Syndrome / virology*
  • Anaphylatoxins / pharmacology
  • Animals
  • Complement System Proteins / immunology*
  • HIV / immunology*
  • HIV / physiology*
  • Humans
  • Tissue Adhesions

Substances

  • Anaphylatoxins
  • Complement System Proteins